These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 32103998)
21. Exosome-mediated Delivery of miR-519e-5p Promotes Malignant Tumor Phenotype and CD8+ T-Cell Exhaustion in Metastatic PTC. Li G; Chen W; Jiang K; Huang J; Zhong J; Liu X; Wei T; Gong R; Li Z; Zhu J; Shi H; Lei J J Clin Endocrinol Metab; 2024 May; 109(6):1601-1617. PubMed ID: 38078691 [TBL] [Abstract][Full Text] [Related]
22. MiR-146b-5p Regulates the Expression of Long Noncoding RNA Peng Y; Fang X; Yao H; Zhang Y; Shi J Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601 [No Abstract] [Full Text] [Related]
23. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer. Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526 [TBL] [Abstract][Full Text] [Related]
24. Plasma-derived exosomal let-7c-5p, miR-335-3p, and miR-652-3p as potential diagnostic biomarkers for stable coronary artery disease. Han J; Cui X; Yuan T; Yang Z; Liu Y; Ren Y; Wu C; Bian Y Front Physiol; 2023; 14():1161612. PubMed ID: 37228823 [No Abstract] [Full Text] [Related]
25. MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells. Lima CR; Geraldo MV; Fuziwara CS; Kimura ET; Santos MF BMC Cancer; 2016 Feb; 16():108. PubMed ID: 26883911 [TBL] [Abstract][Full Text] [Related]
26. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma. Li M; Song Q; Li H; Lou Y; Wang L PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM. Elango R; Alsaleh KA; Vishnubalaji R; Manikandan M; Ali AM; Abd El-Aziz N; Altheyab A; Al-Rikabi A; Alfayez M; Aldahmash A; Alajez NM Front Oncol; 2020; 10():756. PubMed ID: 32509578 [TBL] [Abstract][Full Text] [Related]
28. Circulating exosomal miRNAs as novel biomarkers for acute aortic dissection: A diagnostic accuracy study. Zhang D; Zhao X; Wang B; Liu X; Aizezi A; Ma X Medicine (Baltimore); 2023 Jul; 102(30):e34474. PubMed ID: 37505131 [TBL] [Abstract][Full Text] [Related]
29. Combination of Serum miRNAs with Serum Exosomal miRNAs in Early Diagnosis for Non-Small-Cell Lung Cancer. Wu Q; Yu L; Lin X; Zheng Q; Zhang S; Chen D; Pan X; Huang Y Cancer Manag Res; 2020; 12():485-495. PubMed ID: 32021461 [TBL] [Abstract][Full Text] [Related]
30. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules. Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935 [TBL] [Abstract][Full Text] [Related]
31. Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma. Wang C; Wang J; Cui W; Liu Y; Zhou H; Wang Y; Chen X; Chen X; Wang Z Onco Targets Ther; 2021; 14():1441-1451. PubMed ID: 33664577 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Lee JC; Zhao JT; Clifton-Bligh RJ; Gill A; Gundara JS; Ip JC; Glover A; Sywak MS; Delbridge LW; Robinson BG; Sidhu SB Cancer; 2013 Dec; 119(24):4358-65. PubMed ID: 24301304 [TBL] [Abstract][Full Text] [Related]
33. Identification of Circulating Exosomal microRNAs Associated with Radioiodine Refractory in Papillary Thyroid Carcinoma. Li G; Chen W; Gong Y; Wei T; Gong R; Zhu J; Li Z; Lei J J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556238 [TBL] [Abstract][Full Text] [Related]
34. Expression profile of serum-related exosomal miRNAs from parathyroid tumor. Wang J; Wang Q; Zhao T; Liu X; Bai G; Xin Y; Shen H; Wei B Endocrine; 2021 Apr; 72(1):239-248. PubMed ID: 33161496 [TBL] [Abstract][Full Text] [Related]
35. Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-Up. Rosignolo F; Sponziello M; Giacomelli L; Russo D; Pecce V; Biffoni M; Bellantone R; Lombardi CP; Lamartina L; Grani G; Durante C; Filetti S; Verrienti A J Endocr Soc; 2017 Jan; 1(1):3-13. PubMed ID: 29264441 [TBL] [Abstract][Full Text] [Related]
37. Plasma Exosomal miRNA-122-5p and miR-300-3p as Potential Markers for Transient Ischaemic Attack in Rats. Li DB; Liu JL; Wang W; Luo XM; Zhou X; Li JP; Cao XL; Long XH; Chen JG; Qin C Front Aging Neurosci; 2018; 10():24. PubMed ID: 29467645 [No Abstract] [Full Text] [Related]
38. Decreased serum exosomal miR-29a expression and its clinical significance in papillary thyroid carcinoma. Wen Q; Wang Y; Li X; Jin X; Wang G J Clin Lab Anal; 2021 Jan; 35(1):e23560. PubMed ID: 33368640 [TBL] [Abstract][Full Text] [Related]
39. Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer. Capriglione F; Verrienti A; Celano M; Maggisano V; Sponziello M; Pecce V; Gagliardi A; Giacomelli L; Aceti V; Durante C; Bulotta S; Russo D Endocrine; 2022 Jan; 75(1):185-193. PubMed ID: 34378123 [TBL] [Abstract][Full Text] [Related]
40. miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma. Qiu Z; Li H; Wang J; Sun C Oncol Rep; 2017 Nov; 38(5):2735-2740. PubMed ID: 29048684 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]